Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Predictors of clinical response to biologics in psoriasis: A systematic review and meta-analysis
Xuerui Mao1, Shuo Meng1, Panyu Wu1
1Department of Dermatology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Jiangsu Wuxi, China.
Background:
Biologic therapies have revolutionized psoriasis management, yet inter-individual response varies significantly and reliable predictors of complete skin clearance remain unclear.
Objectives:
This study aimed to identify prognostic predictors of biologic efficacy in patients with psoriasis through a systematic review and meta-analysis.
Methods:
We systematically searched four databases (from their inception to January 28, 2026). Studies were screened and data extracted per predefined criteria; quality was assessed using the Newcastle-Ottawa Scale (NOS), and analyses were performed in Stata 15.0.
Results:
Thirty studies (n = 13,902) were included. Negative predictors of clearance included older age (odds ratio [OR] 0.99, 95% CI 0.98-0.99, p < 0.001), higher body mass index (OR 0.94, 95% CI 0.92-0.97, p < 0.001), comorbidities (OR 0.75, 95% CI 0.63-0.9, p = 0.002), and involvement of special areas (OR 0.71, 95% CI 0.56-0.89, p = 0.003). Conversely, a positive family history (OR 1.42, 95% CI 1.18-1.71, p < 0.001) emerged as a significant predictor associated with better outcomes. No significant associations were observed for other analysed variables.
Conclusions:
Older age, higher comorbidity burden, obesity, and special-site involvement are associated with poorer biologic response in psoriasis, whereas family history is associated with better outcomes. These readily available baseline factors facilitate phenotype-based risk stratification and may guide treatment selection in clinical practice.
Related Concept Videos
Factors Affecting Drug Response: Overview
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drug Products: Biologics, Biosimilars and Interchangeables
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Measurement of Bioavailability: Pharmacodynamic Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

